We are live on ! Find out more
LCS

Levin Capital Strategies Portfolio holdings

AUM $1.49B
1-Year Est. Return 30.44%
This Fund
S&P 500
This Quarter Est. Return
+13.38%
1 Year Est. Return
+30.44%
3 Year Est. Return
+88.58%
5 Year Est. Return
+121.05%
10 Year Est. Return
+327.07%
AUM
$744M
AUM Growth
+$5.93M
Cap. Flow
-$65.5M
Cap. Flow %
-8.8%
Top 10 Hldgs %
39.66%
Holding
303
New
62
Increased
47
Reduced
54
Closed
61

Sector Composition

Rank Sector Weight
1 Financials 18.7%
2 Consumer Discretionary 12.92%
3 Healthcare 10.89%
4 Industrials 10.63%
5 Consumer Staples 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HARP
176
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$239K 0.03%
+33,000
New +$278K
WFC icon
177
Wells Fargo
WFC
$264B
$234K 0.03%
5,677
NEX
178
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$231K 0.03%
25,000
TENB icon
179
Tenable Holdings
TENB
$4.17B
$229K 0.03%
+6,000
New +$220K
LSXMA
180
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$228K 0.03%
7,907
EDR
181
DELISTED
Endeavor Group Holdings, Inc.
EDR
$225K 0.03%
+10,000
New +$213K
BX icon
182
Blackstone
BX
$110B
$222K 0.03%
2,990
LIN icon
183
Linde
LIN
$226B
$216K 0.03%
+661
New +$207K
PANW icon
184
Palo Alto Networks
PANW
$313B
$209K 0.03%
+3,000
New +$241K
BA icon
185
Boeing
BA
$184B
$208K 0.03%
+1,094
New +$179K
WT icon
186
WisdomTree
WT
$3.33B
$207K 0.03%
38,000
-12,000
-24% -$62.4K
HUBB icon
187
Hubbell
HUBB
$27.5B
$203K 0.03%
+866
New +$208K
DNMR
188
DELISTED
Danimer Scientific, Inc.
DNMR
$197K 0.03%
2,750
+1,950
+244% +$184K
PRME icon
189
Prime Medicine
PRME
$591M
$197K 0.03%
+10,585
New +$191K
VTRS icon
190
Viatris
VTRS
$18.7B
$189K 0.03%
+16,956
New +$177K
RIVN icon
191
PUT
Rivian
RIVN
$23.7B
$184K 0.02%
+10,000
New +$294K
TPBA
192
DELISTED
TPB Acquisition Corporation I Class A Ordinary Share
TPBA
$175K 0.02%
+17,451
New +$173K
CS
193
DELISTED
Credit Suisse Group
CS
$170K 0.02%
55,860
+45,000
+414% +$175K
SMMT icon
194
Summit Therapeutics
SMMT
$12.1B
$166K 0.02%
39,176
GLRE icon
195
Greenlight Captial
GLRE
$503M
$163K 0.02%
20,000
+10,000
+100% +$78K
HOOD icon
196
PUT
Robinhood
HOOD
$84.9B
$163K 0.02%
+20,000
New +$196K
ACAH
197
DELISTED
Atlantic Coastal Acquisition Corp. Class A Common Stock
ACAH
$150K 0.02%
15,000
CMTG icon
198
Claros Mortgage Trust
CMTG
$261M
$147K 0.02%
+10,000
New +$157K
RSI icon
199
Rush Street Interactive
RSI
$2.91B
$144K 0.02%
40,000
+22,000
+122% +$81.6K
MNTV
200
DELISTED
Momentive Global Inc. Common Stock
MNTV
$141K 0.02%
+20,157
New +$145K

Similar funds

Levin Capital Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Levin Capital Strategies held 303 positions worth $744M, up 0.8% from $738M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Levin Capital Strategies withdrew a net $65.5M in Q4 2022, closing 61 positions and reducing 54 holdings. Its most notable exit was Aerie Pharmaceuticals, an estimated $17M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Levin Capital Strategies opened a new position in Fomento Económico Mexicano worth $11.1M.

  • Levin Capital Strategies's largest Q4 2022 buy was Fomento Económico Mexicano: 142,318 shares worth $11.1M.
  • Levin Capital Strategies added most to California Resources in Q4 2022, an estimated $10.5M increase.
  • Levin Capital Strategies's biggest Q4 2022 reduction was Apple, cutting an estimated $7.27M.
  • Levin Capital Strategies fully exited Aerie Pharmaceuticals in Q4 2022, selling an estimated $17M.
  • Levin Capital Strategies's ten largest holdings make up 40% of its $744M portfolio in Q4 2022.
  • Levin Capital Strategies opened 62 new positions and closed 61 in Q4 2022.
  • Levin Capital Strategies's portfolio value rose 0.8% quarter-over-quarter to $744M.

Based on Levin Capital Strategies's 13F filing for Q4 2022, filed 13 Feb 2023.